Total Payments
$5,372
2024 Payments
$526.40
Companies
34
Transactions
239
Medicare Patients
11,940
Medicare Billing
$998,210
Payment Breakdown by Category
Food & Beverage$4,865 (90.6%)
Travel$506.83 (9.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,865 | 236 | 90.6% |
| Travel and Lodging | $506.83 | 3 | 9.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,083 | 38 | $0 (2024) |
| ABIOMED | $701.03 | 23 | $0 (2024) |
| PFIZER INC. | $605.81 | 48 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $537.66 | 35 | $0 (2024) |
| Penumbra, Inc. | $239.43 | 2 | $0 (2022) |
| Medtronic, Inc. | $238.62 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $232.82 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $167.68 | 12 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $151.17 | 10 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $146.98 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $526.40 | 31 | ABIOMED ($159.71) |
| 2023 | $776.88 | 35 | ABIOMED ($317.99) |
| 2022 | $860.15 | 25 | Medtronic, Inc. ($238.62) |
| 2021 | $595.13 | 14 | Penumbra, Inc. ($138.08) |
| 2020 | $125.45 | 9 | ABIOMED ($32.89) |
| 2019 | $635.99 | 27 | PFIZER INC. ($202.98) |
| 2018 | $886.07 | 36 | BOSTON SCIENTIFIC CORPORATION ($600.17) |
| 2017 | $965.47 | 62 | BOSTON SCIENTIFIC CORPORATION ($195.42) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $23.90 | General |
| Category: Endovascular | ||||||
| 12/17/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $18.78 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $0.76 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 12/03/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $9.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $7.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $7.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: Endovascular | ||||||
| 09/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $23.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $40.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Not Applicable | ||||||
| 09/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $10.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Cardiology | ||||||
| 08/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.99 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $10.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardio-renal | ||||||
| 07/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $22.39 | General |
| 05/31/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.19 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/16/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Not Applicable | ||||||
| 04/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 3,046 | 4,350 | $813,376 | $251,510 |
| 2022 | 27 | 2,922 | 4,182 | $759,164 | $237,431 |
| 2021 | 26 | 2,909 | 3,623 | $777,418 | $246,751 |
| 2020 | 25 | 3,063 | 3,975 | $826,060 | $262,518 |
Total Patients
11,940
Total Services
16,130
Medicare Billing
$998,210
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 497 | 658 | $154,630 | $58,107 | 37.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 302 | 318 | $137,694 | $41,977 | 30.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 214 | 214 | $108,549 | $32,360 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 247 | 258 | $41,796 | $15,492 | 37.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 85 | 243 | $38,880 | $14,912 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 125 | 125 | $44,750 | $14,225 | 31.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 77 | 77 | $34,573 | $10,377 | 30.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 762 | 969 | $54,264 | $9,671 | 17.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 99 | 102 | $46,530 | $8,586 | 18.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 42 | 168 | $22,512 | $6,961 | 30.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 31 | 33 | $22,737 | $6,878 | 30.3% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 11 | 11 | $15,268 | $5,056 | 33.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 50 | $11,550 | $4,624 | 40.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 78 | 79 | $12,877 | $4,160 | 32.3% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 12 | 475 | $12,350 | $3,919 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $5,056 | $2,126 | 42.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 52 | 95 | $6,745 | $1,758 | 26.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 69 | 124 | $6,448 | $1,685 | 26.1% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 28 | 31 | $3,167 | $1,189 | 37.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 21 | 21 | $3,213 | $1,165 | 36.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 12 | 14 | $3,500 | $1,148 | 32.8% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 51 | 51 | $3,111 | $960.89 | 30.9% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 11 | 11 | $2,431 | $810.37 | 33.3% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 17 | 29 | $3,770 | $782.77 | 20.8% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 12 | 13 | $1,833 | $639.40 | 34.9% |
About Dr. Jonathan Davis, MD
Dr. Jonathan Davis, MD is a Cardiovascular Disease healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801079330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Davis, MD has received a total of $5,372 in payments from pharmaceutical and medical device companies, with $526.40 received in 2024. These payments were reported across 239 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,865).
As a Medicare-enrolled provider, Davis has provided services to 11,940 Medicare beneficiaries, totaling 16,130 services with total Medicare billing of $998,210. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Shreveport, LA
- Active Since 12/06/2007
- Last Updated 07/06/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1801079330
Products in Payments
- Impella (Device) $701.03
- LifeVest (Device) $537.66
- CROSSBOSS (Device) $533.65
- ELIQUIS (Drug) $420.35
- Indigo System (Device) $239.43
- COREVALVE EVOLUT R (Device) $138.01
- VIAGRA (Drug) $137.01
- CHANTIX (Drug) $126.46
- Vascepa (Drug) $125.00
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $120.70
- PRADAXA (Drug) $113.50
- ENTRESTO (Drug) $111.11
- GENERAL VASCULAR INTERVENTION (Device) $103.49
- COBALT DR MRI SURESCAN (Device) $100.61
- MULTAQ (Drug) $90.47
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $84.43
- Corlanor (Drug) $69.70
- GENERAL - ULTRASOUND (Device) $64.40
- XARELTO (Drug) $62.37
- Arcalyst (Drug) $62.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Shreveport
William Eaves, Md, MD
Cardiovascular Disease — Payments: $63,396
Cardiovascular Disease $63,396
Dr. James Smith, M.d, M.D
Cardiovascular Disease — Payments: $59,052
Cardiovascular Disease $59,052
Dr. Paul Davis, M.d, M.D
Cardiovascular Disease — Payments: $56,634
Cardiovascular Disease $56,634
Tarek Helmy, Md, MD
Cardiovascular Disease — Payments: $51,880
Cardiovascular Disease $51,880
Anil Chhabra, Md, MD
Cardiovascular Disease — Payments: $48,787
Cardiovascular Disease $48,787
Eric Reeves, M.d, M.D
Cardiovascular Disease — Payments: $37,592
Cardiovascular Disease $37,592